Logo

Early Sequencing

Aug 14, 2012

The US National Institutes of Health has announced that it is "seeking proposals for research projects on the implications of information obtained from sequencing the genome to identify diseases in newborns," says a press release from the agency. "The use of expanded genomic information has the potential to significantly impact newborn screening in both the clinical and public health setting and benefit numerous infants and children," says Tiina Urv from the Eunice Kennedy Shriver National Institute of Child Health and Human Development in a statement. "However, it is vital that the use of genomic technology in newborns is explored in a thoughtful manner by teams of scientists who develop technology, treat children, and examine the ethical, legal and societal implications of implementing such programs." Daily Scan's sister publication GenomeWeb Daily News has more on this $25 million announcement here.

Breaking News
The Scan

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.

Circulating Tumor DNA Linked to Post-Treatment Relapse in Breast Cancer

Post-treatment detection of circulating tumor DNA may identify breast cancer patients who are more likely to relapse, a new JCO Precision Oncology study finds.

Genetics Influence Level of Depression Tied to Trauma Exposure, Study Finds

Researchers examine the interplay of trauma, genetics, and major depressive disorder in JAMA Psychiatry.

UCLA Team Reports Cost-Effective Liquid Biopsy Approach for Cancer Detection

The researchers report in Nature Communications that their liquid biopsy approach has high specificity in detecting all- and early-stage cancers.